Bz-L-Ala-OMe

Bz-L-Ala-OMe is an L-alanine methyl ester bearing a benzyl (Bz) carbonyl protecting group on the amino functionality, yielding a chiral amino acid ester with a single stereogenic center at the alpha carbon. The molecule contains an N-acylated amide (benzoyl-protected amine), an ester carbonyl suitable for controlled hydrolysis or transesterification, and a benzoyl aromatic ring that can influence solubility and chromatographic behavior during peptide-related synthesis. The protected amide and ester establish orthogonal reactivity patterns: benzoyl deprotection can be addressed under acyl-removal conditions, while the methyl ester can be selectively converted to carboxylic acid derivatives for subsequent coupling. As a chiral amino acid intermediate, Bz-L-Ala-OMe is compatible with peptide building-block workflows where N-protection and C-terminal activation are managed to preserve stereochemical integrity.

1. Peptide Synthesis

Bz-L-Ala-OMe is applied in peptide building-block preparation and stepwise chain assembly where an N-acyl-protected alanine unit and a C-terminal ester handle are required. The benzoyl-protected amide nitrogen suppresses side reactions during coupling steps, while the methyl ester can be converted to a carboxylate equivalent for amide bond formation using standard peptide coupling chemistry. Stereochemistry at the L-alpha center is retained through ester activation and subsequent transformations, supporting the construction of alanine-containing peptides and peptide fragments. Downstream conversion to acid or activated ester forms enables incorporation into longer sequences, making the compound suitable for synthetic methodology development and protected amino acid synthesis.

2. Chiral Amino Acid Intermediate

Bz-L-Ala-OMe serves as a chiral amino acid intermediate for stereoselective synthesis planning in fine chemical and research-grade manufacturing. The L-configuration at the alpha carbon provides a defined stereochemical identity for downstream derivatization, including conversion of the methyl ester to other carboxylate derivatives and controlled N-deprotection to regenerate a free amino group when needed. The benzoyl group provides a robust handle for managing chemoselectivity relative to the ester carbonyl, enabling sequential functional group transformations without racemization under appropriate conditions. The resulting derivatives can be used to access protected alanine analogs, peptide coupling partners, and stereochemically defined intermediates for broader amino acid chemistry campaigns.

3. Pharmaceutical Intermediate Preparation

Bz-L-Ala-OMe is utilized in pharmaceutical intermediate preparation where protected amino acid esters and N-acylated building blocks are required for controlled assembly of peptide-like scaffolds. The benzoyl-protected amine and methyl ester provide orthogonal functional group reactivity that can be leveraged to design manufacturing routes for peptide fragments, peptidomimetic precursors, and amino acid-derived intermediates. Ester-to-acid or ester-to-activated forms can feed into subsequent coupling steps, while benzoyl deprotection can be timed to match downstream purification and coupling requirements. The ability to maintain an L-alanine stereocenter while manipulating protected functional groups supports process chemistry for structured small molecules and intermediate supply chains.

4. Side-Chain Functionalization

Bz-L-Ala-OMe is suitable for amino acid derivatization workflows that require a protected alanine framework prior to downstream functional group installation. The molecule's ester carbonyl can undergo hydrolysis or transesterification to generate carboxylic acid or alternative ester derivatives that participate in further coupling or derivatization chemistry. Benzoyl protection on the nitrogen allows selective transformations at the C-terminal functionality without interference from a free amine, supporting controlled generation of new amide, mixed anhydride, or activated carboxyl derivatives. Functionalized alanine-containing products derived from this intermediate can be used to build SAR-focused libraries, generate peptide analogs, or supply defined chiral fragments for chemical biology studies.

5. Analytical Standards Development

Bz-L-Ala-OMe can be employed as an analytical reference material and method-development standard in amino acid ester and protected amino acid chemistry. The combination of a benzoyl chromophore and a methyl ester provides distinct chromatographic and spectroscopic signatures that facilitate monitoring of protection, deprotection, and ester-to-acid conversion steps during peptide building-block synthesis. The defined L-stereochemistry and protected functional groups help distinguish it from free alanine or differently protected analogs in method qualification workflows. Use in analytical research supports accurate tracking of intermediate identity and impurity profiles across protected amino acid synthesis and peptide coupling sequences.

1. An interdomain binding site on HIV-1 Nef interacts with PACS-1 and PACS-2 on endosomes to down-regulate MHC-I

2. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate

3. Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line

4. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)